You are here

  • Home
  • Archive
  • Volume 79, Issue Suppl 1
  • SAT0145 EFFICACY AND SAFETY OF UPADACITINIB MONOTHERAPY IN MTX-NAÏVE PATIENTS WITH EARLY ACTIVE RA RECEIVING TREATMENT WITHIN 3 MONTHS OF DIAGNOSIS: A POST-HOC ANALYSIS OF THE SELECT-EARLY

Article metrics

Article menu
Download PDFPDF
Scientific Abstracts
Poster Presentations
Saturday, 06 June 2020
Rheumatoid arthritis - non biologic treatment and small molecules
SAT0145 EFFICACY AND SAFETY OF UPADACITINIB MONOTHERAPY IN MTX-NAÏVE PATIENTS WITH EARLY ACTIVE RA RECEIVING TREATMENT WITHIN 3 MONTHS OF DIAGNOSIS: A POST-HOC ANALYSIS OF THE SELECT-EARLY

 

Online download statistics by month:

Online download statistics by month: June 2020 to March 2024

AbstractFullPdf
Jun 202042011
Jul 202026013
Aug 20201809
Sep 202022015
Oct 202020024
Nov 202014011
Dec 2020605
Jan 20213205
Feb 20213401
Mar 2021602
Apr 2021601
May 2021700
Jun 2021002
Jul 2021001
Sep 2021001
Oct 20211800
Nov 20212000
Dec 20211000
Jan 20221000
Feb 2022800
Mar 20221500
Apr 20223001
May 20222400
Jun 2022600
Jul 20221300
Aug 20223001
Sep 2022800
Oct 2022800
Nov 20221500
Dec 20221000
Jan 2023800
Feb 20231000
Mar 20231001
Apr 20231000
May 2023200
Jun 2023100
Jul 20231300
Aug 2023600
Sep 20231200
Oct 2023800
Nov 2023400
Dec 20231400
Jan 2024400
Feb 20241000
Mar 20241101
Total5810105